THESE days, any celebrity with a newly svelte figure has to face speculation about whether their secret weapon is the weight-loss drug semaglutide (also known as Wegovy or Ozempic). Gossip like this might give the impression that these injections are chiefly a cosmetic treatment, but the celebrity examples are a distraction from their intended use.
Such treatments have the potential to reverse the decades-long trend of rising obesity rates 鈥� especially as future versions look set to be more potent still (see 鈥淏eyond Wegovy: Could the next wave of weight-loss drugs end obesity?鈥�). But in some quarters of the media and the medical community, using these drugs is condemned as an unwise 鈥渜uick fix鈥� or even as cheating.
Advertisement
This reaction is illogical. Doctors have been wringing their hands for years about rising obesity. Unfortunately, it is very difficult for most people to lose weight and keep it off through diet and exercise alone. Now, we have a pharmaceutical aid that helps people stick to their diet.
And yet those who really need the drugs are being judged for taking them. When a UK minister recently announced that England鈥檚 health service would be expanding access to the medicines, critics said the government should instead push to change the food industry to make it easier for people to eat healthily and lose weight the natural way. The trouble is that many governments have tried a range of tactics to reverse the obesity epidemic, from clearer food labelling to bans on junk food marketing. Nothing has worked.
That isn鈥檛 to say governments should stop trying. But if we ever do find an effective dietary nudge, it is likely to be only one part of the solution.
Of course, as with any new class of drug, there are unknowns and well-founded concerns. We must also be wary of their potential impact in promoting unrealistic and conformist beauty ideals.
However, turning around the obesity juggernaut will take all the tools available, so to reject the first effective one for decades would be the height of foolishness. If these new medicines do turn out to be a quick fix, doctors should be cheering.
